Shares of Conmed (NYSE:CNMD) moved higher by 4.42% in after-market trading after the company reported Q2 results.
Earnings per share decreased 112.50% over the past year to ($0.07), which beat the estimate of ($0.95).
Revenue of $157,785,000 declined by 33.78% year over year, which beat the estimate of $126,590,000.
Earnings guidance hasn't been issued by the company for now.
Conmed hasn't issued any revenue guidance for the time being.
Details Of The Call
Date: Jul 29, 2020
Time: 04:30 PM
ET Webcast URL: https://edge.media-server.com/mmc/p/dannmu9s
52-week high: $116.81
52-week low: $37.66
Price action over last quarter: Up 11.96%
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgery. The firm currently reports through two reporting units, orthopedic surgery (52% of 2018 sales) and general surgery (48%). From a geographic perspective the firm is U.S. centric, with domestic sales accounting for 52% of revenue, EMEA accounting for 19%, APAC at 17%, and the non-U.S. Americas region driving the remaining 12%.
See more from Benzinga
© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.